Skip to main content
. Author manuscript; available in PMC: 2023 Apr 14.
Published in final edited form as: Alcohol Clin Exp Res. 2022 Apr 14;46(4):657–666. doi: 10.1111/acer.14802

Table 2.

Model performance metrics in cross validation and hold out site samples

NIR Sensitivity Specificity PPV NPV Kappa ICI AUC
Final month
 10-fold CV 0.51 0.67 (0.61; 0.69) 0.64 (0.62; 0.70) 0.66 (0.62; 0.70) 0.65 (0.61; 0.69) 0.32 (0.26; 0.37) 0.74
 LSO site 1 0.52 0.70 (0.57; 0.80) 0.59 (0.46; 0.71) 0.65 (0.53; 0.76) 0.64 (0.50; 0.76) 0.28 (0.12; 0.45) 0.05 0.71
 LSO site 2 0.51 0.67 (0.54; 0.78) 0.70 (0.58; 0.81) 0.70 (0.57; 0.81) 0.67 (0.55; 0.78) 0.37 (0.21; 0.53) 0.04 0.72
 Combined LSO 0.52 0.68 (0.60; 0.76) 0.65 (0.56; 0.73) 0.67 (0.59; 0.75) 0.66 (0.57; 0.74) 0.33 (0.21; 0.44) 0.03 0.71
First month
 10-fold CV 0.53 0.76 (0.72; 0.79) 0.45 (0.41; 0.50) 0.61 (0.57; 0.64) 0.63 (0.58; 0.68) 0.22 (0.16; 0.27) 0.67
 LSO site 1 0.59 0.86 (0.76; 0.93) 0.41 (0.28; 0.55) 0.68 (0.58; 0.77) 0.67 (0.48; 0.82) 0.28 (0.12; 0.44) 0.06 0.70
 LSO site 2 0.52 0.52 (0.39; 0.65) 0.75 (0.63; 0.85) 0.63 (0.52; 0.73) 0.65 (0.50; 0.78) 0.27 (0.11; 0.43) 0.04 0.69
 Combined LSO 0.56 0.81 (0.73, 0.87) 0.47 (0.37; 0.56) 0.66 (0.55; 0.76) 0.66 (0.58; 0.72) 0.28 (0.17; 0.40) 0.04 0.70
Heavy drinking between sessions
 10-fold CV 0.66 0.77 (0.75; 0.79) 0.85 (0.84; 0.86) 0.73 (0.71; 0.74) 0.88 (0.87; 0.89) 0.61 (0.59; 0.63) 0.89
 LSO site 1 0.60 0.71 (0.65; 0.76) 0.85 (0.81; 0.88) 0.76 (0.70; 0.81) 0.81 (0.77; 0.85) 0.56 (0.50; 0.62) 0.17 0.87
 LSO site 2 0.66 0.54 (0.48; 0.60) 0.90 (0.86; 0.92) 0.73 (0.66; 0.79) 0.79 (0.75; 0.82) 0.46 (0.40; 0.53) 0.14 0.80
 Combined LSO 0.63 0.63 (0.89; 0.67) 0.87 (0.85; 0.89) 0.75 (0.70; 0.78) 0.80 (0.77; 0.83) 0.52 (0.48; 0.57) 0.15 0.84

Note. NIR is no information rate. PPV is positive predictive value. NPV is negative predictive value. AUC is area under the receiver operating characteristic curve. ICI is integrated calibration index. LSO is leave site out. Parenthetical values are 95% confidence intervals.